Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

105 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

NCT03219333

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
Locations
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
View all 81 locations
View Trial Details
Completed

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

NCT02928406

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +7 more
Locations
  • Inst. Alexander Fleming; Oncologia Buenos Aires, Argentina
  • Hospital Aleman Caba, Argentina
  • Hospital Britanico de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
  • Canberra Hospital; Medical Oncology Canberra, Australian Capital Territory, Australia
View all 175 locations
View Trial Details
Completed

A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)

NCT02603432

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Anschutz Cancer Center Pavilion Pharmacy Aurora, Colorado, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) Aurora, Colorado, United States
View all 382 locations
View Trial Details
Completed

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

NCT03339843

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +32 more
Locations
  • Universitair Ziekenhuis Antwerp, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Algemeen Ziekenhuis Groeninge Kortrijk, Belgium
  • CHC Saint-Joseph Liège, Belgium
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details

Related conditions